📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
29%
🔁 Convertible Conversion
40%
• Significant convertible debt: 23% potential dilution
• Elevated convertible risk (60/100)
🔄 Reverse Split
30%
• 50-day avg $1.61 approaching $1 threshold
💹 Market Data
Market Cap$16.36M
Shares Outstanding9.74M
Float9.20M
Cash$2.97M
Debt$1.04M
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest7.3K
Days to Cover1.0
% of Float0.1%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Jun 30, 2016
xbrl
XBRL WARRANT
Jan 11, 2013
4
INSIDER TRANSACTION
Apr 01, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for PCSV
📊 PCSV FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 PCSV Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.